Antwerp’s Sightera Biosciences raises €3 million to scale its patient-derived AI drug discovery platform

Sightera Biosciences, an Antwerp-based AI drug discovery startup and spin-off from the University of Antwerp (UA) and Antwerp University Hospital (UZA), today announced the closing of a €3 million pre-Seed financing led by Entourage, Anacura and QBIC. The company plans to use this funding to expand the team, accelerate the expansion of its AI-native drug […] The post Antwerp’s Sightera Biosciences raises €3 million to scale its patient-derived AI drug discovery platform appeared first on EU-Startups .